Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 9Phase 1/2 5Phase 3 3Phase NA 2Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 11Neoplasms 8Vomiting 6Nausea 5Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain, Postoperative 2Neoplasm, Residual 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms 2Wrist Fractures 1Systemic Inflammatory Response Syndrome 1Supratentorial Neoplasms 1Radicular Cyst 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Mediastinal Neoplasms 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Cyclophosphamide 4Vincristine 2selinexor 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1apatinib 1VAP-cyclo protocol 1Thiotepa 1Rituximab 1Radiotherapy 1R-CHOP protocol 1Prednisone 1Nurse Clinicians 1Methotrexate 1Melphalan 1Lomustine 1Ifosfamide 1Idarubicin 1Filgrastim 1Etoposide 1Epirubicin 1Doxorubicin 1Dexamethasone 1Decitabine 1Cytarabine 1Carmustine 1Brentuximab Vedotin 1Blood Pressure 1Antiretroviral Therapy, Highly Active 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Large B-Cell, Diffuse × Dexamethasone × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡